Loss of ERα involved-HER2 induction mediated by the FOXO3a signaling pathway in fulvestrant-resistant breast cancer.

Karouji K., Tominari T., Abe R., Sugasaki M., Ikeda K., Matsumoto C., Miyaura C., Miyata S., Nomura Y., Itoh Y., Hirata M., Inada M.

DOI

10.1016/j.bbrc.2024.151056

Type

Journal

Biochemical and Biophysical Research Communications

Publisher

Elsevier BV

Publication Date

11/2024

Pages

151056 - 151056

Permalink Original publication